Conquering the complex world of human septins: Implications for health and disease

Clinical Genetics

Volumn 77, Issue 6, 2010, Pages 511-524

  Peterson, E A ^b   Petty, E M ^a  

^a Department of Human Genetics ^*  (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Cell division; GTPases; Human septins; Neurological disorders; SEPT9

Indexed keywords

GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; ISOPROTEIN; SEPT1 PROTEIN; SEPT10 PROTEIN; SEPT11 PROTEIN; SEPT12 PROTEIN; SEPT13 PROTEIN; SEPT14 PROTEIN; SEPT2 PROTEIN; SEPT3 PROTEIN; SEPT4 PROTEIN; SEPT5 PROTEIN; SEPT6 PROTEIN; SEPT7 PROTEIN; SEPT8 PROTEIN; SEPT9 PROTEIN; SEPTIN; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE BINDING PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; APOPTOSIS; AUTOSOMAL DOMINANT INHERITANCE; CARCINOGENESIS; CELL CYCLE; CELL DIVISION; CELL FUNCTION; CELL MOTILITY; CELL POLARITY; CHROMOSOME SEGREGATION; CYTOLOGY; DNA DAMAGE; EUKARYOTE; EXOCYTOSIS; GENE LOCUS; GENERAL ASPECTS OF DISEASE; HEALTH; HEPATITIS C; HUMAN; HYDROLYSIS; LEUKEMIA; LISTERIOSIS; MICROTUBULE; MUSCLE ATROPHY; MUTATION; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PHYLOGENY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; RETINOPATHY; REVIEW; SOLID TUMOR; SPERMATOGENESIS; AMINO ACID SEQUENCE; DISEASES; GENETICS; METABOLISM; MOLECULAR GENETICS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; DISEASE; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; NERVOUS SYSTEM DISEASES; PHYLOGENY;

EUKARYOTA; HEPATITIS C VIRUS; LISTERIA; SACCHAROMYCETALES;

EID: 77953951585     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01392.x     Document Type: Review

References (114)

1. Hartwell LH. Genetic control of the cell division cycle in yeast. IV. Genes controlling bud emergence and cytokinesis. Exp Cell Res 1971, 69:265-276.
2. Cao L, Ding X, Yu W. Phylogenetic and evolutionary analysis of the septin protein family in metazoan. FEBS Lett 2007, 581:5526-5532.
3. Feng S, Chen JK, Yu H. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 1994, 266:1241-1247.
4. Lim WA, Richards FM. Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition. Nat Struct Biol 1994, 1:221-225.
5. Garcia W, de Araujo AP, Neto Mde O. Dissection of a human septin: definition and characterization of distinct domains within human SEPT4. Biochemistry 2006, 45:13918-13931.
6. Low C, Macara IG. Structural analysis of septin 2, 6, and 7 complexes. J Biol Chem 2006, 281:30697-30706.
7. Sirajuddin M, Farkasovsky M, Hauer F. Structural insight into filament formation by mammalian septins. Nature 2007, 449:311-315.
8. Johnson ES, Gupta AA. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 2001, 106:735-744.
9. She YM, Huang YW, Zhang L. Septin 2 phosphorylation: theoretical and mass spectrometric evidence for the existence of a single phosphorylation site in vivo. Rapid Commun Mass Spectrom 2004, 18:1123-1130.
10. Xue J, Milburn PJ, Hanna BT. Phosphorylation of septin 3 on Ser-91 by cGMP-dependent protein kinase-I in nerve terminals. Biochem J 2004, 381:753-760.
11. Xue J, Wang X, Malladi CS. Phosphorylation of a new brain-specific septin, G-septin, by cGMP-dependent protein kinase. J Biol Chem 2000, 275:10047-10056.
12. Qi M, Yu W, Liu S. Septin1, a new interaction partner for human serine/threonine kinase aurora-B. Biochem Biophys Res Commun 2005, 336:994-1000.
13. Sanders SL, Field CM. Cell division. Septins in common? Curr Biol 1994, 4:907-910.
14. Kinoshita M, Kumar S, Mizoguchi A. Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures. Genes Dev 1997, 11:1535-1547.
15. Neufeld TP, Rubin GM. The Drosophila peanut gene is required for cytokinesis and encodes a protein similar to yeast putative bud neck filament proteins. Cell 1994, 77:371-379.
16. Nguyen TQ, Sawa H, Okano H. The C. elegans septin genes, unc-59 and unc-61, are required for normal postembryonic cytokineses and morphogenesis but have no essential function in embryogenesis. J Cell Sci 2000, 113(Pt 21):3825-3837.
17. Zhang J, Kong C, Xie H. Phosphatidylinositol polyphosphate binding to the mammalian septin H5 is modulated by GTP. Curr Biol 1999, 9:1458-1467.
18. Field CM, Kellogg D. Septins: cytoskeletal polymers or signalling GTPases? Trends Cell Biol 1999, 9:387-394.
19. Kartmann B, Roth D. Novel roles for mammalian septins: from vesicle trafficking to oncogenesis. J Cell Sci 2001, 114:839-844.
20. Gonzalez ME, Peterson EA, Privette LM. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res 2007, 67:8554-8564.
21. Hall PA, Jung K, Hillan KJ. Expression profiling the human septin gene family. J Pathol 2005, 206:269-278.
22. Kremer BE, Haystead T, Macara IG. Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4. Mol Biol Cell 2005, 16:4648-4659.
23. Nagata K, Kawajiri A, Matsui S. Filament formation of MSF-A, a mammalian septin, in human mammary epithelial cells depends on interactions with microtubules. J Biol Chem 2003, 278:18538-18543.
24. Surka MC, Tsang CW, Trimble WS. The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis. Mol Biol Cell 2002, 13:3532-3545.
25. Gottfried Y, Rotem A, Lotan R. The mitochondrial ARTS protein promotes apoptosis through targeting XIAP. Embo J 2004, 23:1627-1635.
26. Larisch S. The ARTS connection: role of ARTS in apoptosis and cancer. Cell Cycle 2004, 3:1021-1023.
27. Larisch S, Yi Y, Lotan R. A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nat Cell Biol 2000, 2:915-921.
28. Beites CL, Campbell KA, Trimble WS. The septin Sept5/ CDCrel-1 competes with alpha-SNAP for binding to the SNARE complex. Biochem J 2005, 385:347-353.
29. Beites CL, Xie H, Bowser R. The septin CDCrel-1 binds syntaxin and inhibits exocytosis. Nat Neurosci 1999, 2:434-439.
30. Hsu SC, Hazuka CD, Roth R. Subunit composition, protein interactions, and structures of the mammalian brain sec6/8 complex and septin filaments. Neuron 1998, 20:1111-1122.
31. Huang YW, Yan M, Collins RF. Mammalian septins are required for phagosome formation. Mol Biol Cell 2008, 19:1717-1726.
32. Blaser S, Horn J, Wurmell P. The novel human platelet septin SEPT8 is an interaction partner of SEPT4. Thromb Haemost 2004, 91:959-966.
33. Blaser S, Roseler S, Rempp H. Human endothelial cell septins: SEPT11 is an interaction partner of SEPT5. J Pathol 2006, 210:103-110.
34. Dent J, Kato K, Peng XR. A prototypic platelet septin and its participation in secretion. Proc Natl Acad Sci U S A 2002, 99:3064-3069.
35. Martinez C, Corral J, Dent JA. Platelet septin complexes form rings and associate with the microtubular network. J Thromb Haemost 2006, 4:1388-1395.
36. Ahuja P, Perriard E, Trimble W. Probing the role of septins in cardiomyocytes. Exp Cell Res 2006, 312:1598-1609.
37. Spiliotis ET, Kinoshita M, Nelson WJ. A mitotic septin scaffold required for mammalian chromosome congression and segregation. Science 2005, 307:1781-1785.
38. Spiliotis ET, Hunt SJ, Hu Q. Epithelial polarity requires septin coupling of vesicle transport to polyglutamylated microtubules. J Cell Biol 2008, 180:295-303.
39. Kremer BE, Adang LA, Macara IG. Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell 2007, 130:837-850.
40. Lin YH, Lin YM, Wang YY. The expression level of septin12 is critical for spermiogenesis. Am J Pathol 2009, 174:1857-1868.
41. Steels JD, Estey MP, Froese CD. Sept12 is a component of the mammalian sperm tail annulus. Cell Motil Cytoskeleton 2007, 64:794-807.
42. Sugino Y, Ichioka K, Soda T. Septins as diagnostic markers for a subset of human asthenozoospermia. J Urol 2008, 180:2706-2709.
43. Ihara M, Kinoshita A, Yamada S. Cortical organization by the septin cytoskeleton is essential for structural and mechanical integrity of mammalian spermatozoa. Dev Cell 2005, 8:343-352.
44. Mostowy S, Cossart P. Cytoskeleton rearrangements during Listeria infection: clathrin and septins as new players in the game. Cell Motil Cytoskeleton 2009, 66:816-823.
45. Mostowy S, Danckaert A, Tham TN. Septin 11 restricts InlB-mediated invasion by Listeria. J Biol Chem 2009, 284:11613-11621.
46. Mostowy S, Nam Tham T, Danckaert A. Septins regulate bacterial entry into host cells. PLoS ONE 2009, 4:e4196.
47. Peterson EA, Kalikin LM, Steels JD. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin. Mamm Genome 2007, 18:796-807.
48. Zhu M, Wang F, Yan F. Septin 7 interacts with centromere-associated protein E and is required for its kinetochore localization. J Biol Chem 2008, 283:18916-18925.
49. Kinoshita A, Kinoshita M, Akiyama H. Identification of septins in neurofibrillary tangles in Alzheimer's disease. Am J Pathol 1998, 153:1551-1560.
50. Choi P, Snyder H, Petrucelli L. SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res 2003, 117:179-189.
51. Zhang Y, Gao J, Chung KK. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A 2000, 97:13354-13359.
52. Ihara M, Tomimoto H, Kitayama H. Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies. J Biol Chem 2003, 278:24095-24102.
53. Fujishima K, Kiyonari H, Kurisu J. Targeted disruption of Sept3, a heteromeric assembly partner of Sept5 and Sept7 in axons, has no effect on developing CNS neurons. J Neurochem 2007, 102:77-92.
54. Xue J, Tsang CW, Gai WP. Septin 3 (G-septin) is a developmentally regulated phosphoprotein enriched in presynaptic nerve terminals. J Neurochem 2004, 91:579-590.
55. Ito H, Atsuzawa K, Morishita R. Sept8 controls the binding of vesicle-associated membrane protein 2 to synaptophysin. J Neurochem 2009, 108:867-880.
56. Kinoshita N, Kimura K, Matsumoto N. Mammalian septin Sept2 modulates the activity of GLAST, a glutamate transporter in astrocytes. Genes Cells 2004, 9:1-14.
57. Buser AM, Erne B, Werner HB. The septin cytoskeleton in myelinating glia. Mol Cell Neurosci 2009, 40:156-166.
58. Hannibal MC, Ruzzo EK, Miller LR. SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy. Neurology 2009, 72:1755-1759.
59. Kuhlenbaumer G, Hannibal MC, Nelis E. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet 2005, 37:1044-1046.
60. Landsverk ML, Ruzzo EK, Mefford HC. Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy. Hum Mol Genet 2009, 18:1200-1208.
61. McDade SS, Hall PA, Russell SE. Translational control of SEPT9 isoforms is perturbed in disease. Hum Mol Genet 2007, 16:742-752.
62. Megonigal MD, Rappaport EF, Jones DH. t(11;22) (q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc Natl Acad Sci U S A 1998, 95:6413-6418.
63. Borkhardt A, Teigler-Schlegel A, Fuchs U. An ins(X;11) (q24;q23) fuses the MLL and the septin 6/KIAA0128 gene in an infant with AML-M2. Genes Chromosomes Cancer 2001, 32:82-88.
64. Cerveira N, Correia C, Bizarro S. SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23). Oncogene 2006, 25:6147-6152.
65. Kojima K, Sakai I, Hasegawa A. FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Leukemia 2004, 18:998-1005.
66. Osaka M, Rowley JD, Zeleznik-Le NJ. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci U S A 1999, 96:6428-6433.
67. Meyer C, Schneider B, Jakob S. The MLL recombinome of acute leukemias. Leukemia 2006, 20:777-784.
68. Ernst P, Wang J, Korsmeyer SJ. The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol 2002, 9:282-287.
69. Capurso G, Crnogorac-Jurcevic T, Milione M. Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas. Neuroendocrinology 2005, 81:311-321.
70. Kim DS, Hubbard SL, Peraud A. Analysis of mammalian septin expression in human malignant brain tumors. Neoplasia 2004, 6:168-178.
71. Tanaka M, Kijima H, Itoh J. Impaired expression of a human septin family gene Bradeion inhibits the growth and tumorigenesis of colorectal cancer in vitro and in vivo. Cancer Gene Ther 2002, 9:483-488.
72. Amir S, Wang R, Matzkin H. MSF-A interacts with hypoxia-inducible factor-1 alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 2006, 66:856-866.
73. Burrows JF, Chanduloy S, McIlhatton MA. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol 2003, 201:581-588.
74. Kalikin LM, Sims HL, Petty EM. Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors. Genomics 2000, 63:165-172.
75. Montagna C, Lyu MS, Hunter K. The septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003, 63:2179-2187.
76. Scott M, Hyland PL, McGregor G. Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours. Oncogene 2005, 24:4688-4700.
77. Scott M, McCluggage WG, Hillan KJ. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int J Cancer 2006, 118:1325-1329.
78. Yu W, Ding X, Chen F. The phosphorylation of SEPT2 on Ser218 by casein kinase 2 is important to hepatoma carcinoma cell proliferation. Mol Cell Biochem 2009, 325:61-67.
79. Craven RA, Stanley AJ, Hanrahan S. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 2006, 6:2853-2864.
80. Kalikin LM, Frank TS, Svoboda-Newman SM. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors. Oncogene 1997, 14:1991-1994.
81. Kalikin LM, Qu X, Frank TS. Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on 17q25. Genes Chromosomes Cancer 1996, 17:64-68.
82. Russell SE, McIlhatton MA, Burrows JF. Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Res 2000, 60:4729-4734.
83. Macara IG, Baldarelli R, Field CM. Mammalian septins nomenclature. Mol Biol Cell 2002, 13:4111-4113.
84. Taki T, Ohnishi H, Shinohara K. AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). Cancer Res 1999, 59:4261-4265.
85. Corral J, Lavenir I, Impey H. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 1996, 85:853-861.
86. Sorensen AB, Lund AH, Ethelberg S. Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J Virol 2000, 74:2161-2168.
87. Hall PA, Russell SE. The pathobiology of the septin gene family. J Pathol 2004, 204:489-505.
88. McIlhatton MA, Burrows JF, Donaghy PG. Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene 2001, 20:5930-5939.
89. Bennett KL, Karpenko M, Lin MT. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 2008, 68:4494-4499.
90. Bennett KL, Lee W, Lamarre E. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes Cancer 2009, 49:319-326.
91. Giefing M, Arnemann J, Martin-Subero JI. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. Br J Haematol 2008, 142:916-924.
92. Devos T, Tetzner R, Model F. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009, 55:1337-1346.
93. Grutzmann R, Molnar B, Pilarsky C. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE 2008, 3:e3759.
94. Lofton-Day C, Model F, Devos T. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008, 54:414-423.
95. Amir S, Mabjeesh NJ. SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents. Cancer Biol Ther 2007, 6:1926-1931.
96. Amir S, Wang R, Simons JW. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation. J Biol Chem 2009, 284:11142-11151.
97. Setlur SR, Mertz KD, Hoshida Y. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst 2008, 100:815-825.
98. Ito H, Iwamoto I, Morishita R. Possible role of Rho/ Rhotekin signaling in mammalian septin organization. Oncogene 2005, 24:7064-7072.
99. Nagata K, Inagaki M. Cytoskeletal modification of Rho guanine nucleotide exchange factor activity: identification of a Rho guanine nucleotide exchange factor as a binding partner for Sept9b, a mammalian septin. Oncogene 2005, 24:65-76.
100. Gonzalez ME, Makarova O, Peterson EA. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells. Cell Signal 2009, 21:477-487.
101. Kissel H, Georgescu MM, Larisch S. The Sept4 septin locus is required for sperm terminal differentiation in mice. Dev Cell 2005, 8:353-364.
102. Xin X, Pache M, Zieger B. Septin expression in proliferative retinal membranes. J Histochem Cytochem 2007, 55:1089-1094.
103. Pache M, Zieger B, Blaser S. Immunoreactivity of the septins SEPT4, SEPT5, and SEPT8 in the human eye. J Histochem Cytochem 2005, 53:1139-1147.
104. Baretton G, Vogt T, Valina C. Prostate cancers and potential precancerous conditions: DNA cytometric investigations and interphase cytogenetics. Verh Dtsch Ges Pathol 1993, 77:86-92.
105. Kinoshita M, Field CM, Coughlin ML. Self- and actin-templated assembly of Mammalian septins. Dev Cell 2002, 3:791-802.
106. Joo E, Surka MC, Trimble WS. Mammalian SEPT2 is required for scaffolding nonmuscle myosin II and its kinases. Dev Cell 2007, 13:677-690.
107. Fujishima K, Kiyonari H, Kurisu J. Targeted disruption of Sept3, a heteromeric assembly partner of Sept5 and Sept7 in axons, has no effect on developing CNS neurons. J Neurochem 2007, 102:77-92.
108. Ding X, Yu W, Liu M. SEPT12 interacts with SEPT6 and this interaction alters the filament structure of SEPT6 in Hela cells. J Biochem Mol Biol 2007, 40:973-978.
109. Nagata K, Asano T, Nozawa Y. Biochemical and cell biological analyses of a mammalian septin complex, Sept7/9b/11. J Biol Chem 2004, 279:55895-55904.
110. Nagata K, Inagaki M. Cytoskeletal modification of Rho guanine nucleotide exchange factor activity: identification of a Rho guanine nucleotide exchange factor as a binding partner for Sept9b, a mammalian septin. Oncogene 2005, 24:65-76.
111. Ding X, Yu W, Liu M. GTP binding is required for SEPT12 to form filaments and to interact with SEPT11. Mol Cells 2008, 25:385-389.
112. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Books, The NCBI handbook [Internet], Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2002 Oct. Chapter 18, The Reference Sequence (RefSeq) Project. Available from
113. Eyre TA, Ducluzeau F, Sneddon TP, Povey S, Bruford EA, Lush MJ. The HUGO Gene Nomenclature Database, 2006 updates. Nucleic Acids Res 2006, D319-21. Jan 1; 34 (Database issue):
114. http://www.genenames.org, HGNC Database, HUGO Gene Nomenclature Committee (HGNC), EMBL Outstation-Hinxton, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK, November 2009.